Will NCT06717711 (Regina Elena Cancer Institute) still show a study completion date of 28 February 2028 or earlier when checked on 29 March 2028?
deadline 2028-03-29
confidence medium
tier 4 evidence
39%PolySignal estimate
Resolution criterion
Yes if, when NCT06717711 is read on clinicaltrials.gov on 29 March 2028, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 28 February 2028 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.
Verified starting state
As of 7 October 2026: NCT06717711 is registered as RECRUITING, sponsored by Regina Elena Cancer Institute, with 158 participants. Started 2023-09; announced primary completion 2027-02-28, announced study completion 2028-02-28. Record last updated 2026-08-14. The date under test is 2028-02-28. Source: clinicaltrials.gov/study/NCT06717711
What pushes it up
- The trial has been active since September 2023 and was updated in August 2026, showing ongoing sponsor engagement [1].
What pushes it down
- Oncology trials frequently face recruitment bottlenecks, leading to a high likelihood of completion date extensions [2].
- Academic and institutional sponsors often experience administrative delays in updating trial registries, which could lead to an 'Unknown' status if not updated promptly after the completion date [2].
What would move this number most
Whether the trial meets its recruitment target of 158 participants on schedule by early 2027 to allow study completion by February 2028.
How this number is built
| Deadline | 2028-03-29 |
| Base rate | 40% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 38 · 40 (spread 2 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-07 21:16 |
| Model | gemini-3.5-flash |